Navigation Links
New insights come from tracing cells that irreversibly scar lungs
Date:12/1/2011

DURHAM, N.C. -- Tracking individual cells within the lung as they move around and multiply has given Duke University researchers new insights into the causes of Idiopathic Pulmonary Fibrosis (IPF) a disease which can only be treated now by lung transplantation.

IPF fills the delicate gas exchange region of the lung with scar tissue, progressively restricting breathing. The Duke University Medical Center researchers have discovered that some commonly held ideas about the origins of the scar-forming (fibrotic) cells are oversimplified, if not wrong.

We are the first to show that pericytes, a population of cells previously described to play a role in the development of fibrosis in other organs, are present in fibrotic lung tissue, said Christina Barkauskas, M.D., a pulmonary fellow in the Duke Division of Pulmonary, Allergy and Critical Care Medicine.

The team found that pericytes move from blood vessels into fibrotic regions, and were in the damaged lungs of both humans and mice. In mice, they also showed that the epithelial cells, which make up the lacy sacs called alveoli, could divide and repair the damage in the gas-exchange location, but these cells were not the source of scarring.

Idiopathic pulmonary fibrosis affects about 100,000 people in the U.S. each year and leads to death within three years of diagnosis.

The study was published the week of Nov. 28 in PNAS Plus online edition.

We dont know yet whether the pericytes make the scar matrix itself or just release signals that stimulate the scarring process, but either way, they are a potential target for new therapies, said Brigid Hogan, Ph.D., senior author and chair of the Duke Department of Cell Biology.

The researchers used genetic lineage tracing to study the origin of cells that gathered in fibrotic areas. They gave several different cell types an indelible fluorescent tag and then followed the cells over time.

The cells kept the tag even if they multiplied, migrated within the lung, or differentiated into another cell type.

Paul Noble, M.D., co-author and chief of the Pulmonary Division at Duke, said that identifying the source of the lethal expansion of the scarring (fibroblast) cells is a critical missing link in understanding disease progression.

Previous studies had suggested that the epithelial cells in the alveoli are a source of fibroblast accumulation after lung injury, he said.

This study used the newest tracing approaches to conclusively demonstrate, however, that the alveolar epithelium isnt a significant source for fibroblast accumulation following lung injury in mice, Noble said. The studies suggest that there may be several sources for the scar-forming cell accumulation in fibrosis, including pericytes, which hadnt been implicated in lung fibrosis until now.

Noble said that the study data provide new insights into the sources of scar-forming cells and would help to target the correct cell population that causes disease progression.

Now the researchers are focusing on what these cells may make that could promote a healing process. One idea is that perhaps in IPF these epithelial cells have lost the ability to repair damage to the lung, so that scarring continues inexorably and cannot be restrained perhaps we could find a way to assist the repair process, Hogan said. Promoting the healing process might be another therapeutic approach.


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Related biology news :

1. New papers offer insights into process of malarial drug resistance
2. Mixing genomics and geography yields insights into life and environment
3. New insights into a leading poultry disease and its risks to human health
4. New paper offers key insights into how new species emerge
5. Mixed population provides insights into human genetic makeup
6. Addiction: Insights from Parkinsons disease
7. Lohafex provides new insights on plankton ecology
8. New insights into progressive hearing loss
9. First neuroimaging study examining motor execution in children with autism reveals new insights
10. Limping rat provides sciatica insights
11. Researchers gain genome-wide insights into patterns of the worlds human population structures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology: